Mahesh Krishnan Chinook Therapeutics, Inc. (KDNY) insider trading activity

KDNY Quotes by TradingView

Mahesh Krishnan is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 1,275 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mahesh Krishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
1,275 Reduced 100.0%
0 Common Stock
Apr 04 2023
SELL
Open market or private sale
$21,261 $23.01 p/Share
924 Reduced 42.02%
1,275 Common Stock
Apr 01 2023
BUY
Exercise of conversion of derivative security
-
2,199 Added 50.0%
2,199 Common Stock

Also insider at

HALO
HALOZYME THERAPEUTICS, INC. Healthcare
MK

Mahesh Krishnan

Director
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KDNY